Candida vulvovaginitis secondary prevention
Jump to navigation
Jump to search
|
Candida vulvovaginitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Candida vulvovaginitis secondary prevention On the Web |
|
American Roentgen Ray Society Images of Candida vulvovaginitis secondary prevention |
|
Risk calculators and risk factors for Candida vulvovaginitis secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
- For prevention of recurrent vulvovaginal candidiasis, maintenance fluconazole prophylaxis may be used.[1]
- Treatment of a male sexual partner with oral ketoconazole does not seem to influence the cure or recurrence rates in women with Candida vulvovaginitis.[2][3][4]
Secondary Prevention
- For prevention of recurrent vulvovaginal candidiasis, maintenance fluconazole prophylaxis may be used.[1]
- Treatment of a male sexual partner with oral ketoconazole does not seem to influence the cure or recurrence rates in women with Candida vulvovaginitis.[2][3][4]
References
- ↑ 1.0 1.1 Sobel JD (2007). "Vulvovaginal candidosis". Lancet. 369 (9577): 1961–71. doi:10.1016/S0140-6736(07)60917-9. PMID 17560449.
- ↑ 2.0 2.1 Fong IW (1992). "The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole". Genitourin Med. 68 (3): 174–6. PMC 1194850. PMID 1607194.
- ↑ 3.0 3.1 Shihadeh AS, Nawafleh AN (2000). "The value of treating the male partner in vaginal candidiasis". Saudi Med J. 21 (11): 1065–7. PMID 11360070.
- ↑ 4.0 4.1 Bisschop MP, Merkus JM, Scheygrond H, van Cutsem J (1986). "Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study". Br J Obstet Gynaecol. 93 (1): 79–81. PMID 3510660.